Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thor...
TILT Biotherapeutics Competitors or Alternatives
TILT Biotherapeutics's top competitors include Sorrento, Tessa and Tmunity.
TILT Biotherapeutics VS Sorrento
Sorrento is a top competitor of TILT Biotherapeutics. Sorrento was founded in 1989, and is headquartered in San Diego, California. Like TILT Biotherapeutics, Sorrento also competes in the Biotechnology field. Sorrento generates $60.3M more revenue vs. TILT Biotherapeutics.
TILT Biotherapeutics VS Tessa
Tessa is seen as one of TILT Biotherapeutics's top competitors. Tessa is headquartered in Singapore, Central Singapore, and was founded in 2012. Like TILT Biotherapeutics, Tessa also operates in the Biotechnology field. Tessa generates 167% the revenue of TILT Biotherapeutics.
TILT Biotherapeutics VS Tmunity
Tmunity has been one of TILT Biotherapeutics's top competitors. Tmunity's headquarters is in Philadelphia, Pennsylvania, and was founded in 2015. Like TILT Biotherapeutics, Tmunity also works within the Biotechnology industry. Tmunity generates 125% of TILT Biotherapeutics's revenue.
Looking for similar companies to TILT Biotherapeutics?
Similar Companies
Biotechnology companies in Helsinki
See 20 companies
Pharmaceuticals & Biotechnology companies in HelsinkiSee 42 companies
Biotechnology companies in Southern FinlandSee 28 companies
Pharmaceuticals & Biotechnology companies in Southern FinlandSee 44 companies
Biotechnology companies in FinlandSee 107 companies
Pharmaceuticals & Biotechnology companies in FinlandSee 174 companies
Companies in Southern Finland with employees in 1-25 rangeSee 471 companies
Companies in Helsinki with employees in 1-25 rangeSee 586 companies
Companies in Southern Finland with revenue in $100K-5.0M rangeSee 654 companies
Trending News for TILT Biotherapeutics and TILT Biotherapeutics's Competitors
HAMBURG (dpa-AFX) - Germany-headquartered life science company Evotec SE (EVT, EVO) on Thursday announced further significant progress in the company's...
LONDON, April 22, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), an early commercial stage biopharmaceutical company developing, manu...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced three upcoming presentations at the 2025 American Society of Clinical Oncology...
The Global CAR-T cell therapy market reached US$ 4.8 billion in 2024 and is expected to reach US$ 20.4 billion by 2033, growing at a CAGR of 16.3% duri...
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2025 dividend on the company's common stock, payabl...
(The third paragraph has been corrected to reflect that Deutsche Bank has abandoned its sell recommendation. FRANKFURT (dpa-AFX Broker) - Evotec shares...
The Global Multiple Myeloma Market reached USD 20.2 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 31.3 billion by ...
The latest release from WMR titled Drug Manufacturing Solutions Market Research Report 2025-2032 (by Product Type, End-User / Application, and Regions ...
Frequently Asked Questions about TILT Biotherapeutics
Who are TILT Biotherapeutics's top competitors?
TILT Biotherapeutics's top 3 competitors are Sorrento, Tessa, Tmunity.Who is similar to TILT Biotherapeutics?
Sorrento is the most similar to TILT Biotherapeutics. Tessa and Tmunity are also similar to TILT Biotherapeutics.
Are TILT Biotherapeutics and Sorrento competitors?
Yes, Sorrento is one of TILT Biotherapeutics’s top competitors.